Pharmacology 6th Semester 2 Marks Important Questions | B Pharm 6th Semester
This is a B.Pharmacy 6th Semester Pharmacology video covering important 2-mark questions from all five units. The instructor explains key pharmacological concepts including COPD drugs, antibiotics, antiviral agents, monoclonal antibodies, and toxicology. Students are directed to Telegram for PDF notes covering other subjects' 2-mark questions.
Summary
The video is a guided walkthrough of important 2-mark questions for B.Pharmacy 6th Semester Pharmacology, presented in Hindi. The instructor begins by informing students that while video explanations are being provided for Pharmacology, PDF materials for other subjects will be available on the Telegram channel, as the priority is completing remaining 4th and 5th unit syllabus videos first.
Unit 1 topics covered include: drugs used in COPD management (salbutamol, terbutaline, formoterol, theophylline, aminophylline), anticholinergics (atropine, ipratropium) and their mechanism of blocking acetylcholine, digestants (pepsin, diastase, papain), nasal decongestants (oxymetazoline, xylometazoline), emetics (apomorphine, ipecac syrup, copper sulfate) and their use in poisoning/food poisoning cases, etiology of asthma (smoking, cold/dry air, air pollution, food chemicals, genetic history, medications), appetite stimulants acting on the hypothalamic hunger center, and expectorants vs antitussives for wet vs dry cough respectively.
Unit 2 covers chemotherapy (strong chemical drugs used in cancer treatment that target rapidly dividing cells), antibiotics classified as bactericidal or bacteriostatic (penicillin, amoxicillin, azithromycin, tetracycline), adverse effects of penicillin (allergic reactions, rash, itching, anaphylaxis, diarrhea), cephalosporins and their uses in various bacterial infections, adverse effects of chloramphenicol (bone marrow suppression, aplastic anemia, grey baby syndrome), and sulfonamides mechanism (inhibiting folic acid synthesis in bacteria, thereby blocking DNA synthesis) along with side effects like allergic reactions, photosensitivity, crystalluria, and hemolytic anemia.
Unit 3 discusses acyclovir as an antiviral agent that inhibits viral DNA polymerase and causes chain termination by incorporating itself into the growing DNA chain after activation by viral enzymes. Antimalarial drugs covered include chloroquine, quinine, primaquine, and artesunate. Leprosy treatment uses a combination of dapsone, rifampicin, and clofazimine. Chemical classification of antimalarials is briefly mentioned, and anti-tubercular agents are classified into first-line drugs (isoniazid, rifampicin, pyrazinamide, ethambutol — given as a 4-drug combination for 9-11 months) and second-line drugs used in multi-drug resistant TB. Anti-amoebic drugs (metronidazole, tinidazole, ornidazole, iodoquinol) and anthelmintics for treating various worm infections (pinworm, hookworm, filarial worm, tapeworm, roundworm) are also mentioned.
Unit 4 covers monoclonal antibodies in detail — explaining epitopes on antigen surfaces, how specific B cells produce specific antibodies, and how cloning a single B cell type produces monoclonal antibodies (versus polyclonal). Their applications include cancer cell targeting, autoimmune diseases, diagnostics, and targeted drug delivery. Biosimilars are explained as the biological equivalent of generic drugs — highly similar but not identical to original biologics (like insulin) due to the variability inherent in living-organism-based production, available after patent expiry of the original biologic. Immunostimulants and immunosuppressants, malignancy (abnormal uncontrolled cell growth that invades nearby tissues), and protein drugs (insulin, erythropoietin, monoclonal antibodies) are also briefly discussed.
Unit 5 focuses on toxicology: genotoxicity (damage to DNA/genetic material), teratogenicity (birth defects caused during pregnancy), barbiturate poisoning symptoms (CNS depression, drowsiness, respiratory depression), heavy metal poisoning (lead and mercury), carcinogenicity (ability of a substance to cause cancer), chronopharmacology (how the body's biological clock/circadian rhythm affects drug action — e.g., prescribing antihypertensives at night because BP tends to rise in the morning), mutagenicity (DNA mutations leading to abnormal cell growth), and acute vs chronic toxicity (immediate vs long-term toxic effects).
Key Insights
- The instructor explains that acyclovir works by first being activated by a viral enzyme, then inhibiting viral DNA polymerase, and finally incorporating itself between DNA chain fragments to cause chain termination — thereby stopping viral DNA synthesis entirely.
- The instructor distinguishes monoclonal from polyclonal antibodies by explaining that monoclonal antibodies are derived from clones of a single B cell type, making them highly specific not just to one antigen but to one particular epitope (zone) on that antigen's surface.
- The instructor clarifies that biosimilars are not exact copies of original biologics — unlike chemical generic drugs which are 100% identical — because biologics are made using living organisms, introducing inherent variability of approximately 0.1-1%, meaning the biosimilar could perform slightly better or slightly worse than the original.
- The instructor uses chronopharmacology to explain that antihypertensive drugs are sometimes prescribed at night specifically because blood pressure tends to spike in the morning, demonstrating how the body's circadian rhythm directly influences optimal drug dosing timing.
- The instructor explains that first-line TB treatment uses a fixed four-drug combination — isoniazid, rifampicin, pyrazinamide, and ethambutol — over 9 to 11 months, and that second-line drugs are only used when patients develop multi-drug resistance, often due to non-compliance or prior antibiotic overuse.
Topics
Full transcript available for MurmurCast members
Sign Up to Access